All News #Library
Biotech
AffyImmune to Present ICAM-1 CAR T Therapy AIC100 at AACR 2025
28 Apr 2025 //
PR NEWSWIRE
AffyImmune Appoints Deyaa Adib, MD as Chief Medical Officer
25 Nov 2024 //
PR NEWSWIRE
AffyImmune Adds Drs Rutter And Nieva To Board Of Directors
23 Sep 2024 //
BUSINESSWIRE
Affyimmune Complete Anaplastic: Thyroid Cancer Response Confirmed
23 May 2024 //
BUSINESSWIRE
AffyImmune Announces Clinical to Support Development of AIC100 in Solid Tumors
08 Apr 2024 //
BUSINESSWIRE

Market Place
Sourcing Support